Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

NexMed reports progress with topical treatments for sexual dysfunction

Sep. 9, 1999

FibroGen and Taisho to collaborate on kidney fibrosis research

Sep. 8, 1999

YM-31758: a potent and selective inhibitor of human prostatic 5alpha-reductase

Sep. 6, 1999

New treatment for urinary incontinence in the Recordati pipeline

Aug. 31, 1999

Long-term continuation rate good for Alza's overactive bladder therapy

Aug. 30, 1999

Long-term tolterodine reduces incontinence, is well tolerated

Aug. 30, 1999

Ferring's antidiuretic agent F-992 evaluated in healthy volunteers

Aug. 26, 1999

ACS news: Wyeth-Ayerst investigates agents for urinary incontinence

Aug. 23, 1999

Sanofi-Synthelabo submits MAA for Ditropan XL in the U.K.

Aug. 16, 1999

Leading BPH treatment to be copromoted by Abbott and Boehringer Ingelheim

Aug. 16, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...